Link_TSG6: link protein for inflammatory bone disorders

  • Product Overview: Novel link protein for treatment of bone inflammatory disorders
  • Primary Indication(s); Osteoporosis, Osteoarthritis
  • Core differentiators:
    1. Novel MoA
    2. Potent inhibition of bone resorption; minimal inhibition of none formation
    3. Associated with chondroprotective properties
    4. Inhibition of neutrophil migration
    5. Readily expressed in E coli – ‘drugable’
  • Development Stage: PreClinical
  • Company/ Institution: University of Manchester; manchester.ac.uk (www.manchester.ac.uk/research/Anthony.day/research)
  • Opportunity: Available for licensing, sponsored research and investment